Toll-like receptor 4 mutations

   
   

The present invention relates, in general, to toll-like receptor 4 (TLR4) mutations and, in particular, to a method of assessing the susceptibility of an individual to atherosclerosis and to a method of treating an individual identified as being at increased risk.

 
Web www.patentalert.com

< Valved over-the-wire catheter

< Access port system for anastomosis

> PYK2 and inflammation

> Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors

~ 00192